AMH (Anti-Müllerian Hormone) is a key biomarker for ovarian reserve, reflecting the remaining egg pool. Low AMH can indicate reduced fertility potential, but it is not a standalone predictor of pregnancy success. Fertility depends on age, hormone balance, egg quality, partner factors, and lifestyle. AMH alone cannot reliably predict menopause timing or natural conception outcomes. Our context does not include direct AMH data or genetic variants linked to AMH levels. The evidence for AMH as a fertility marker is human-observational, not deterministic. Caveat: AMH testing should be interpreted clinically, not as a sole decision tool. For family planning, comprehensive medical evaluation is recommended.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-3979e9cf69b0ab6e0db5136b